Lisa M Berglund Selected Research

A 285222

1/2018	In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 mice.
1/2014	Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.
11/2012	NFATc3 regulates trypsinogen activation, neutrophil recruitment, and tissue damage in acute pancreatitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa M Berglund Research Topics

Disease

3	Hyperglycemia 12/2017 - 01/2014
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 03/2012
2	Inflammation (Inflammations) 01/2016 - 11/2012
2	Necrosis 01/2013 - 11/2012
1	Congenital Abnormalities (Deformity) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Pathologic Constriction (Stenosis) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2017
1	Proteinuria 12/2017
1	Albuminuria 12/2017
1	Amaurosis Fugax 01/2016
1	Transient Ischemic Attack 01/2016
1	Chronic Limb-Threatening Ischemia 01/2016
1	Stroke (Strokes) 01/2016
1	Atherosclerosis 01/2014
1	Weight Gain 10/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2013
1	Hemorrhage 11/2012
1	Edema (Dropsy) 11/2012
1	Pancreatitis 11/2012
1	Neointima 03/2012
1	Rupture 03/2012
1	Type 2 Diabetes Mellitus (MODY) 09/2011

Drug/Important Bio-Agent (IBA)

3	A 285222IBA 01/2018 - 11/2012
3	Proteins (Proteins, Gene)FDA Link 12/2017 - 03/2012
3	Messenger RNA (mRNA)IBA 01/2016 - 09/2011
2	Streptozocin (Streptozotocin)FDA Link 12/2017 - 01/2014
2	transcription factor NF-AT c3IBA 01/2015 - 11/2012
2	Triglycerides (Triacylglycerol)IBA 01/2014 - 10/2013
2	CholesterolIBA 01/2014 - 10/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018
1	Insulin (Novolin)FDA Link 12/2017
1	AlbuminsIBA 12/2017
1	EnzymesIBA 01/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Endothelin-1 (Endothelin 1)IBA 01/2016
1	gastric inhibitory polypeptide receptorIBA 01/2016
1	LipidsIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	LuciferasesIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	ApolipoproteinsIBA 01/2014
1	CytokinesIBA 01/2014
1	OsteopontinIBA 01/2014
1	Retinal Pigments (Pigments, Visual)IBA 01/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Peroxidase (Myeloperoxidase)IBA 11/2012
1	Taurocholic Acid (Sodium Taurocholate)IBA 11/2012
1	TrypsinogenIBA 11/2012
1	Amylases FDA Link 11/2012
1	InterferonsIBA 03/2012

Therapy/Procedure

1	Osteotomy 01/2021
1	Aftercare (After-Treatment) 01/2018
1	Carotid Endarterectomy 01/2016
1	Light Coagulation 01/2013